Zobrazeno 1 - 10
of 61
pro vyhledávání: '"Nancy G. Kennaway"'
Publikováno v:
Journal of Clinical Investigation. 115:2784-2792
NADH:ubiquinone oxidoreductase (complex I) deficiency is a common cause of mitochondrial oxidative phosphorylation disease. It is associated with a wide range of clinical phenotypes in infants, including Leigh syndrome, cardiomyopathy, and encephalom
Autor:
Neil R. M. Buist, Nancy G. Kennaway, Roberto Anitori, Eric A. Shoubridge, Franklin Quan, Kara Manning, Richard G. Weleber
Publikováno v:
Molecular Genetics and Metabolism. 84:176-188
We studied three patients, each harboring a novel mutation at a highly conserved position in a different mitochondrial tRNA gene. The mutation in patient 1 (T5543C) was associated with isolated mitochondrial myopathy, and occurred in the anticodon lo
Autor:
Eric A. Shoubridge, Tanja Taivassalo, John Vissing, Ronald G. Haller, Hana Antonicka, Nancy G. Kennaway, Roberto P. Anitori, Isla Ogilvie
Publikováno v:
Journal of Biological Chemistry. 278:43081-43088
Deficiencies in the activity of complex I (NADH: ubiquinone oxidoreductase) are an important cause of human mitochondrial disease. Complex I is composed of at least 46 structural subunits that are encoded in both nuclear and mitochondrial DNA. Enzyme
Autor:
Nancy G. Kennaway, Michaela Jaksch, Hana Antonicka, Cary O. Harding, Eric A. Shoubridge, Jeffrey N. Agar, Scot C. Leary, Rita Horvath, Guy Hellen Guercin
Publikováno v:
Human Molecular Genetics. 12:2693-2702
Deficiencies in the activity of cytochrome c oxidase (COX) are an important cause of autosomal recessive respiratory chain disorders. Patients with isolated COX deficiency are clinically and genetically heterogeneous, and mutations in several differe
Autor:
Salvatore Dimauro, Douglas L. Arnold, Tanja Taivassalo, Ronald G. Haller, Nancy G. Kennaway, Eric A. Shoubridge, Jacqueline T. Chen
Publikováno v:
Annals of Neurology. 50:133-141
Aerobic training has been shown to increase work and oxidative capacity in patients with mitochondrial myopathies, but the mechanisms underlying improvement are not known. We evaluated physiological (cycle exercise, 31P-MRS), biochemical (enzyme leve
Autor:
Nancy G. Kennaway, J. Andrew Keightley, Neil R. M. Buist, Roberto Anitori, Franklin Quan, Miriam D. Burton
Publikováno v:
The American Journal of Human Genetics. 67(6):1400-1410
We have reinvestigated a young woman, originally reported by us in 1983, who presented with exercise intolerance and lactic acidosis associated with severe deficiency of complex III and who responded to therapy with menadione and ascorbate. Gradually
Autor:
Xiao-Yun Hua, Nancy G. Kennaway, Richard H. Haas, Margaret L. Smith, Deborah Marsden, Kim-Yen Ngo, Dou Liu
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 82:2826-2831
A 6-yr-old boy presented with muscle weakness, lactic acidemia, and insulin-dependent diabetes mellitus (IDDM). Using PCR and restriction enzyme analysis, he was found to have the classical A3243G mitochondrial DNA (mtDNA) mutation frequently associa
Autor:
Michael H. Foerster, Nancy G. Kennaway, Ulrich Kellner, Richard G. Weleber, Gerald A. Fishman
Publikováno v:
Retina. 17:403-413
PURPOSE To describe the clinical characteristics of a chorioretinal disease with a gyrate atrophy-like phenotype and normal plasma ornithine. METHODS One family with three men who had progressive chorioretinal disease and three additional patients wi
Autor:
K. C. Hoffbuhr, Nancy G. Kennaway, W. S. W. Johnston, Neil R. M. Buist, V. M. Salas, Melvin D. Burton, J. A. Keightley, A. M. W. Penn
Publikováno v:
Nature Genetics. 12:410-416
We have identified a 15-bp microdeletion in a highly conserved region of the mitochondrially encoded gene for cytochrome c oxidase (COX) subunit III in a patient with severe isolated COX deficiency and recurrent myoglobinuria. The mutant mitochondria
Autor:
Nancy G. Kennaway, Ching Nan Ou, Carlos A. Torres-Ramos, Markus Grompe, John Papaconstantinou, Muhsen Al-Dhalimy, Milton J. Finegold, Sven Lindstedt
Publikováno v:
Nature Genetics. 10:453-460
Hereditary tyrosinaemia type I, a severe autosomal recessive metabolic disease, affects the liver and kidneys and is caused by deficiency of fumarylacetoacetate hydrolase (FAH). Mice homozygous for a FAH gene disruption have a neonatal lethal phenoty